NCT06568874

Brief Summary

Virtual reality (VR) therapy has shown promising results in improving sensorimotor function of the upper extremity in chronic stroke patients compared to conservative treatments. VR offers immersive, interactive environments that can enhance motivation and engagement in rehabilitation exercises.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 30, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 21, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 23, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2024

Completed
Last Updated

August 23, 2024

Status Verified

August 1, 2024

Enrollment Period

7 months

First QC Date

August 21, 2024

Last Update Submit

August 21, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Fugl-Meyer Assessment (FMA) for Upper Extremity

    The Fugl-Meyer Assessment (FMA) for Upper Extremity is a widely used and validated tool to evaluate motor function, balance, sensation, and joint functioning in individuals who have had a stroke. It specifically assesses the sensorimotor function of the upper extremities. Scoring: The upper extremity section of the FMA includes 33 items, each scored on a scale of 0 to 2: 0: Cannot perform 1. Performs partially 2. Performs fully The maximum score for the upper extremity section is 66, indicating optimal function.

    12 Months

  • Stroke Impact Scale (SIS)

    The Stroke Impact Scale (SIS) is a self-report questionnaire that evaluates the impact of stroke on multiple dimensions, including strength, hand function, activities of daily living (ADL), mobility, communication, emotion, memory, thinking, and participation. Each item is scored on a scale of 1 to 5: 1: Unable to do 5: Not difficult at all Higher scores indicate a lesser impact of stroke on the patient's life.

    12 months

Study Arms (2)

Exp Group

EXPERIMENTAL
Combination Product: Virtual Reality (VR) Therapy

Control Group

ACTIVE COMPARATOR
Diagnostic Test: Conservative Treatment

Interventions

Virtual Reality (VR) TherapyCOMBINATION_PRODUCT

Intervention: Patients in this group will receive therapy using VR technology. This involves engaging in various sensorimotor training exercises and tasks in an immersive virtual environment. The VR sessions are designed to be interactive and adaptive, providing real-time feedback to the user. The exercises will target the improvement of motor functions, coordination, and strength of the affected upper extremity. Duration and Frequency: The specific regimen may involve sessions several times a week, with each session lasting between 30 to 60 minutes, over a period of several weeks or months, depending on the study design.

Exp Group
Conservative TreatmentDIAGNOSTIC_TEST

Intervention: Patients in this group will receive traditional rehabilitation therapies, which may include: Physical Therapy (PT): Exercises and activities aimed at improving strength, flexibility, and coordination of the upper limb. Occupational Therapy (OT): Functional task training to enhance daily living skills and independence, focusing on the use of the upper extremity. Manual Therapy: Techniques such as massage or joint manipulation to improve mobility and reduce pain. Home Exercise Programs: Prescribed exercises to be performed at home to reinforce therapy sessions. Duration and Frequency: Similar to the VR group, this regimen may involve regular sessions several times a week, with each session lasting between 30 to 60 minutes, over a comparable period.

Control Group

Eligibility Criteria

Age4 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients with a confirmed diagnosis of chronic stroke (at least 6 months post-stroke).
  • Age:
  • Upper Extremity Impairment:
  • Ability to provide informed consent to participate in the study.

You may not qualify if:

  • Severe communication difficulties that would impede the ability to follow instructions during therapy.
  • Severe spasticity in the affected upper limb (Modified Ashworth Scale score of 4 or higher).
  • Other Neurological Conditions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Services Hospital,Shadman 1

Lahore, Punjab Province, Pakistan

Location

MeSH Terms

Interventions

Therapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 21, 2024

First Posted

August 23, 2024

Study Start

November 30, 2023

Primary Completion

July 1, 2024

Study Completion

October 30, 2024

Last Updated

August 23, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations